Clinical Pharmacological Study to Investigate the Effects of Mucosta Ophthalmic Suspension UD2% on Ocular Surface Cells in Patients with Dry Eye
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2017
At a glance
- Drugs Rebamipide (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 04 Sep 2017 Status changed from active, no longer recruiting to completed.
- 05 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 05 Dec 2016 Status changed from not yet recruiting to recruiting.